<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04332289</url>
  </required_header>
  <id_info>
    <org_study_id>DEEP1A</org_study_id>
    <nct_id>NCT04332289</nct_id>
  </id_info>
  <brief_title>Assessing Insulin Turnover Using an In-vivo Deuterated Water Experiment.</brief_title>
  <acronym>DEEP1A</acronym>
  <official_title>Deciphering the Enigma of Postprandial Hyperinsulinaemic Hypoglycaemia After Bariatric Surgery, Part 1 A: Assessing Insulin Turnover Using an In-vivo Deuterated Water Experiment. A Proof-of-concept Study.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Lia Bally</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital Inselspital, Berne</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The primary objective of this study is to observe the kinetics of pre-stored and de-novo&#xD;
      synthesized insulin that is secreted into the circulation using an in-vivo heavy water (D2O)&#xD;
      labelling experiment in patients with postprandial hyperinsulinaemic hypoglycaemia (PHH) and&#xD;
      non-surgical non-PHH controls.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Despite an increased prevalence, the underlying pathophysiology of PHH remains incompletely&#xD;
      understood. It is generally assumed that PHH is caused by excess insulin secretion, either&#xD;
      due to an intrinsic beta-cell abnormality (histology showing increased beta-cell mass or&#xD;
      signs of hyperfunction) and/or increased postprandial insulinotropic signals (also known as&#xD;
      the incretin-effect) as a consequence of the re-arranged gastrointestinal tract and&#xD;
      accelerated nutrient transit and absorption. Either of the two explanations would imply an&#xD;
      altered insulin turnover in these patients with higher amounts of pre-stored insulin and/or&#xD;
      accelerated de-novo insulin synthesis in response to stimulus-depletion of the available&#xD;
      insulin pool. A non-invasive in vivo technique to study insulin turnover has not been&#xD;
      established yet and data related to PHH are consequently lacking.&#xD;
&#xD;
      The primary objective of this study is to observe the kinetics of pre-stored and de-novo&#xD;
      synthesized insulin that is secreted into the circulation using an in-vivo heavy water (D2O)&#xD;
      labelling experiment in patients with postprandial hyperinsulinaemic hypoglycaemia (PHH) and&#xD;
      non-surgical non-PHH controls. The investigators hypothesize that the suggested&#xD;
      methodological approach is feasible to assess insulin turnover and provides the foundation&#xD;
      for further studies in different target groups.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">July 9, 2020</start_date>
  <completion_date type="Actual">August 20, 2020</completion_date>
  <primary_completion_date type="Actual">August 13, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Total amount of pre-stored insulin secreted</measure>
    <time_frame>During the 7 days of the heavy water administration period</time_frame>
    <description>Measured using deuterium (2H)-labelled insulin in the plasma</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Time course of the increase in 2H-labelled insulin in plasma</measure>
    <time_frame>During the 7 days of the heavy water administration period</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time course of the increase in 2H-labelled insulin in urine</measure>
    <time_frame>During the 7 days of the heavy water administration period</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time course of the increase in 2H-labelled c-peptide in plasma</measure>
    <time_frame>During the 7 days of the heavy water administration period</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time course of the increase in 2H-labelled c-peptide in urine</measure>
    <time_frame>During the 7 days of the heavy water administration period</time_frame>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">4</enrollment>
  <condition>Bariatric Surgery</condition>
  <condition>Hypoglycemia</condition>
  <condition>Gastric Bypass</condition>
  <arm_group>
    <arm_group_label>PHH patients</arm_group_label>
    <description>Patients following Roux-en-Y gastric bypass surgery (≥1 year ago) with confirmed post-prandial hyperinsulinemic hypoglycemia</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Healthy controls</arm_group_label>
    <description>Non-PHH, non-surgical healthy individuals</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Heavy water experiment</intervention_name>
    <description>3 times daily heavy water (deuterated-water) and mixed meal administration for one week</description>
    <arm_group_label>Healthy controls</arm_group_label>
    <arm_group_label>PHH patients</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Participants will be recruited by referral from our outpatient endocrine clinic and&#xD;
        collaborating Centres of Excellence for Metabolic Surgery. Non-surgical controls will be&#xD;
        recruited through advertisement according to guidelines from swissethics.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion criteria for PHH patients:&#xD;
&#xD;
          -  Aged ≥18 years&#xD;
&#xD;
          -  Roux-en-Y gastric bypass ≥1 year ago&#xD;
&#xD;
          -  PHH defined as postprandial plasma or sensor glucose&lt;3.0mmol/l according to the&#xD;
             International Hypoglycaemia Study Group and exclusion of other causes of hypoglycaemia&#xD;
&#xD;
        Inclusion criteria for non-PHH non-surgical controls:&#xD;
&#xD;
          -  Aged ≥18 years&#xD;
&#xD;
          -  Absence of any condition or previous surgery known to affect gastro-intestinal&#xD;
             integrity and food absorption&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Clinically relevant weight changes (≥5%) within the past 3 months&#xD;
&#xD;
          -  Incapacity to give informant consent&#xD;
&#xD;
          -  Historical or current diabetes based on HbA1c ≥6.5% without glucose-lowering treatment&#xD;
&#xD;
          -  Haemoglobin level below 13.5 g/l&#xD;
&#xD;
          -  Ongoing treatment with glucose-lowering drugs, anorectic drugs, steroids or any&#xD;
             medications known to affect gastric motility&#xD;
&#xD;
          -  Active heart, lung, liver, gastrointestinal, renal or neurological disease&#xD;
&#xD;
          -  Inability to follow study procedures&#xD;
&#xD;
          -  Pregnancy or breast-feeding&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Lia Bally, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Bern University Hospital, University of Bern</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Department of Diabetes, Endocrinology, Clinical Nutrition and Metabolism, Inselspital, Bern University Hospital</name>
      <address>
        <city>Bern</city>
        <zip>3010</zip>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <verification_date>September 2020</verification_date>
  <study_first_submitted>March 30, 2020</study_first_submitted>
  <study_first_submitted_qc>March 31, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">April 2, 2020</study_first_posted>
  <last_update_submitted>September 29, 2020</last_update_submitted>
  <last_update_submitted_qc>September 29, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">October 1, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>University Hospital Inselspital, Berne</investigator_affiliation>
    <investigator_full_name>Lia Bally</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>Insulin turnover</keyword>
  <keyword>Insulin secretion</keyword>
  <keyword>Deuterated Water</keyword>
  <keyword>De-novo insulin synthesis</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypoglycemia</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Deuterium Oxide</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

